Treatment of progressive multiple sclerosis with high-dose all-trans retinoic acid – no clear evidence of positive disease modifying effects

BACKGROUND: All-trans retinoic acid (ATRA) is an acid derivative of vitamin A which is discussed as a promising candidate to ameliorate the disease course of multiple sclerosis (MS) by immunomodulation or even by promoting regeneration in progressive MS. Here we report a patient who significantly im...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruschil, Christoph, Dubois, Evelyn, Stefanou, Maria-Ioanna, Kowarik, Markus Christian, Ziemann, Ulf, Schittenhelm, Marcus, Krumbholz, Markus, Bischof, Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108354/
https://www.ncbi.nlm.nih.gov/pubmed/33966627
http://dx.doi.org/10.1186/s42466-021-00121-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108354/
https://www.ncbi.nlm.nih.gov/pubmed/33966627
http://dx.doi.org/10.1186/s42466-021-00121-4

Ejemplares similares